MiNK Therapeutics, Inc. (INKT) ownership: Top institutional holder: VANGUARD GROUP INC ($754309.00). Insider activity: Net Seller (0 buys, 20 sells). SEC EDGAR first-party data.
| Holder | Shares | Market Value | Reported |
|---|---|---|---|
| VANGUARD GROUP INC | 67651.00 | $754309.00 | 2025-12-31 |
| VANGUARD CAPITAL MANAGEMENT LLC | 59364.00 | $625103.00 | 2026-03-31 |
| GEODE CAPITAL MANAGEMENT, LLC | 17345.00 | $182666.00 | 2026-03-31 |
| Longbow Finance SA | 16667.00 | $175504.00 | 2026-03-31 |
| UBS Group AG | 15202.00 | $160077.00 | 2026-03-31 |
| RENAISSANCE TECHNOLOGIES LLC | 10400.00 | $115960.00 | 2025-12-31 |
| VANGUARD FIDUCIARY TRUST CO | 8287.00 | $87262.00 | 2026-03-31 |
| BlackRock, Inc. | 6203.00 | $65317.00 | 2026-03-31 |
| Insider | Transaction | Value | Date |
|---|---|---|---|
| Sell | null | 2026-06-04 | |
| Sell | null | 2026-06-04 | |
| Sell | null | 2026-03-10 | |
| Sell | null | 2026-03-10 | |
| Sell | null | 2026-03-10 | |
| Sell | null | 2026-03-09 | |
| Sell | null | 2026-03-09 | |
| Sell | null | 2026-03-09 |
Back to INKT overview · INKT earnings · All congressional trades
Institutional data from SEC Form 13F. Insider data from SEC Form 4. Congressional data from STOCK Act disclosures. Not personalized investment advice.